Quintiles.com

  • Latin America

    After entering the South American market in 1995, Quintiles operates facilities in nine countries. These locations are part of our infrastructure that enables the transfer of best practices around the globe.
  • Brazil

    Local Resources:
    Central Lab, Clinical, Product
    Marketing & Sales, Project Management, Regulatory

    Operating since: 1997

    Patients enrolled:
    10,000 - 25,000 in South America (2004-2008)

    Studies
    <250 in South America (12/31/08) (2004-2008)

    Workforce:
    <2,500 in South America

    Go to Brazil

    Chile

    Local Resources:
    Clinical, Project Management
    Regulatory

    Operating since: 2000

    Patients enrolled:
    10,000 - 25,000 in South America (2004 - 2008)

    Studies
    <250 in South America (12/31/08) (2004 - 2008)

    Workforce:
    <2,500 in South America (12/31/08)

    Go to Chile

    Colombia

    Local Resources:
    Clinical, Regulatory

    Operating since: 2004

    Patients enrolled:
    10,000 - 25,000 in South America (2004 - 2008)

    Studies
    <250 in South America (12/31/08) (2004 - 2008)

    Workforce:
    <2,500 in South America (2004 - 2008)

    Go to Colombia

    Costa Rica

    Local Resources:
    Access to Patients, Clinical
    Regulatory Services

    Operating since: 2007

    Patients enrolled:
    200,000 - 250,000 in North America (2004-2008)

    Studies
    >750 in North America (2004 - 2008)

    Workforce:
    5,000 - 10,000 in North America (12/31/08)

    Go to Costa Rica

    Peru

    Local Resources:
    Central Lab, Clinical, Commercial
    Project Management, Regulatory

    Operating since: 2004

    Patients enrolled:
    10,000 - 25,000 in South America (2004-2008)

    Studies
    <250 in South America (2004-2008)

    Workforce:
    <2,500 in South America (12/31/08)

    Go to Peru

  • Latin America Perspectives

  • Quintiles

    Middle East Oncology Capabilities

    Outstanding access to patients in the Middle East region with a population of over 200 million means this is an important emerging region for the biopharmaceutical industry and Quintiles has a proven track record of rapid patient enrollment with high patient retention rates.

  • slider img

    Quintiles Ranked 6th in InformationWeek 500
    slider img

    Computerworld Magazine’s “100 Best Places to Work in IT”
    slider img


    Web Health Award for exceptional content development on ClinicalResearch.com
    slider img

    Ragan Communications Award for Best Social Intranet
    slider img

    Best Clinical Research Organization (CRO) in the Vaccine Industry Excellence (ViE) Awards
    slider img

    Asia Pacific CRO of the Year at the BioPharma Convention Awards

    The work we do with the biopharmaceutical industry, payers and providers has a profound effect on extending patients’ lives and quality of life around the world. Learn More About Quintiles